Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Medacta Group SA is a Swiss-based company specializing in the design, production, and distribution of orthopedic medical devices. The company's core business focuses on hip and knee replacement products, as well as spine surgery and sports medicine solutions. Founded in 1999, Medacta is headquartered in Castel San Pietro, Switzerland. The company distinguishes itself through its commitment to medical education, providing training and resources to healthcare professionals to enhance surgical outcomes. Medacta also emphasizes innovation in minimally invasive surgical techniques and personalized solutions to improve patient care and recovery times.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
Medacta Group SAJohnson & Johnson
Last price
CHF 117.80$273.20
Currency
CHF
USD
CHF 2.3B$658B
33.0641.49
CHF 3.56$6.58
0.970.21
CHF 1.10$5.28
0.47%1.96%
Sector
HealthHealth
Employees
2,273138,200
Ticker
Fr. MOVE$JNJ
Primary listing
XSWXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in Fr.MOVE or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.